Xcout IntelCTT PHARMACEUTICAL HOLDINGS, INC. competitors & alternatives
The 12 closest competitors and alternatives to CTT PHARMACEUTICAL HOLDINGS, INC. among pharmaceuticals companies — ranked by similarity to what CTT PHARMACEUTICAL HOLDINGS, INC. actually does, not by market-cap band.
Subscribe to see CTT PHARMACEUTICAL HOLDINGS, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About CTT PHARMACEUTICAL HOLDINGS, INC.
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.
CTT PHARMACEUTICAL HOLDINGS, INC. at a glance
CTT PHARMACEUTICAL HOLDINGS, INC. is a pharmaceuticals company headquartered in Tampa, United States. It is publicly listed (CTTH) with a market capitalisation of $3.7M. Xcout tracks 3 named people at CTT PHARMACEUTICAL HOLDINGS, INC., including Ryan Khouri (Chief Executive Officer).
CTT PHARMACEUTICAL HOLDINGS, INC. leadership
- Ryan KhouriChief Executive Officer
- Pankaj ModiFounder & Consultant
- Marc LakmaakerSpecial Advisor & Senior Vice President of Commercial Development
Top 12 CTT PHARMACEUTICAL HOLDINGS, INC. competitors
Ranked by semantic similarity — how close each company is to CTT PHARMACEUTICAL HOLDINGS, INC. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology & Pharmaceuticals
NYB Holdings Ltd operates an AI-first drug discovery and biotechnology platform that utilizes a large natural compound library and predictive modeling to identify bioactive compounds. The company develops science-backed wellness solutions for nutraceutical applications and advances high-potential drug candidates into preclinical development for the pharmaceutical industry.
Similar pharmaceuticals company
Flex Pharma is a specialty pharmaceutical company that develops advanced drug delivery formulations to enhance the bioavailability, tolerability, and dosing flexibility of complex or poorly soluble drugs. The company utilizes its proprietary ElectroNanoSpray (ENS) technology platform to assist pharmaceutical innovators in optimizing drug performance for clinical trials and patient care.
Similar pharmaceuticals company
Novilla Pharmaceuticals is a biotechnology company headquartered in Cambridge, Massachusetts, developing a novel class of localized medicines designed by AI to treat pain. The firm focuses on targeted therapeutics that function only where needed within the body. It operates as a privately held startup with a small scientific team.
Similar pharmaceuticals company
Orexo AB is a pharmaceutical company that specializes in developing innovative drug delivery technologies, notably its powder-based AmorphOX platform. The company advances proprietary and partnered pharmaceutical products, including treatments, vaccines, and nasal delivery formulations, serving patients and healthcare partners globally.
Biotechnology
Day Three Labs Inc. is a biotechnology and pharmaceutical formulation company based in Denver, Colorado, founded in 2021. The company specializes in nanodelivery technologies that enhance the bioavailability of cannabinoid and pharmaceutical compounds.
Biotechnology
Biora Therapeutics is a U.S. biotechnology company developing ingestible, device-based platforms for delivering biologic medicines to targeted areas of the gastrointestinal tract and into systemic circulation. Its technologies are intended for use by pharmaceutical and biotechnology companies developing oral or targeted biologic therapies.
Biotech
Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of active pharmaceutical ingredients, enhancing their absorption into the bloodstream. This innovative platform has shown impressive results, boosting the bioavailability of compounds such as cannabinoids and nicotine by 5 to 10 times, and in some cannabinoid applications, by as much as 27 times, when compared to standard formulations. DehydraTECH also drastically cuts the time of onset from hours to mere minutes and effectively neutralizes unpleasant tastes. Beyond its established uses, the technology is currently under evaluation for its potential application with orally administered antiviral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and various other compounds. A notable feature of DehydraTECH is its capacity to facilitate the passage of drugs across the blood-brain barrier. The company operates a licensed internal research facility and holds a substantial intellectual property portfolio, comprising 23 granted patents and roughly 50 pending patent applications globally. Founded in 2004, Lexaria Bioscience Corp. is headquartered in Kelowna, Canada.
Biotechnology
MilanaPharm, LLC is a biotechnology company that develops drug delivery platforms and pharmaceutical products, including topical and local formulations such as Analgea SR and XACIATO. The company focuses on innovative product development to improve patient quality of life in areas such as pain management and women's health.
Biotechnology
Phoreus Biotechnology, Inc. is a privately held biotechnology company founded in 2018 and headquartered in Olathe, Kansas. The company specializes in the development of proprietary nanocarriers for targeted drug delivery and enhanced treatments.
Biotechnology
pHLIP, Inc. is a privately held, clinical-stage biopharmaceutical company located in Kingston, Rhode Island, dedicated to improving patient outcomes using its proprietary pH-Low Insertion Peptide Platform.
Biotechnology
Surf Bio, Inc. is a biotechnology company that collaborates with multinational pharmaceutical firms on drug delivery technologies and therapeutic pipelines.
Biotechnology
Daya CNS, LLC is a preclinical biopharmaceutical company that develops a proprietary non-opioid pyridoindole platform for the treatment of chronic pain, substance abuse disorders, and neuropsychiatric conditions. Its product pipeline includes small molecule medications such as DDD-028 for neuropathic and inflammatory pain, DDD-024 for addiction, and DDD-016 for neuropsychiatric disorders, serving patients with unmet medical needs in neurology and addiction medicine.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of CTT PHARMACEUTICAL HOLDINGS, INC. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for CTT PHARMACEUTICAL HOLDINGS, INC.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →